<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="080474-2018"
            EDITION="2018037">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-081997-001</RECEPTION_ID>
      <DELETION_DATE>20180531</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>37</NO_OJ>
         <DATE_PUB>20180222</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 037-080474</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:080474-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="BE"/>
         <IA_URL_GENERAL>www.acahbelgique.be</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="BE3">RÉGION WALLONNE</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="BE3">RÉGION WALLONNE</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="BE211">Arr. Antwerpen</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="BE310">Arr. Nivelles</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="BE241">Arr. Halle-Vilvoorde</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">3200000.00</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 237-492209</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180220</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Бeлгия</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Belgie</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Belgien</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Belgien</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Βέλγιο</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Belgium</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Bélgica</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Belgique</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Bheilg, an</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Belgija</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Belgium</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Belgio</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Belgija</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Beļģija</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>il-Belġju</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>België</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Bélgica</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Belgicko</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Belgija</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Belgien</TI_CY>
            <TI_TOWN>Erpent</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">Centrale de négociation pour les achats hospitaliers</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Centrale de négociation pour les achats hospitaliers</OFFICIALNAME>
               <ADDRESS>Rue de la Pavée 8</ADDRESS>
               <TOWN>Erpent</TOWN>
               <POSTAL_CODE>5101</POSTAL_CODE>
               <COUNTRY VALUE="BE"/>
               <CONTACT_POINT>Olivier Vargin</CONTACT_POINT>
               <PHONE>+32 81320594</PHONE>
               <E_MAIL>olivier.vargin@acahbelgique.be</E_MAIL>
               <n2016:NUTS CODE="BE3"/>
               <URL_GENERAL>www.acahbelgique.be</URL_GENERAL>
               <URL_BUYER>https://enot.publicprocurement.be/enot-war/preViewNotice.do?noticeId=300170</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CENTRAL_PURCHASING/>
            <CA_TYPE_OTHER>ASBL</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Marché public ayant pour objet la fourniture d’anesthésiques (N01 &amp; N05), de Curares (M03) et d’antidote en cas d’intoxication médicamenteuse (V03AB25)</P>
            </TITLE>
            <REFERENCE_NUMBER>ACAH-Anesthésiques-AOO-2017-67-F03_2</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Marché public ayant pour objet la fourniture d’anesthésiques (N01 &amp; N05), de Curares (M03) et d’antidote en cas d’intoxication médicamenteuse (V03AB25).</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">3200000.00</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Propofol — Voie injectable (Ampoule &amp; Vial)</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Propofol — Voie injéctable (Ampoule &amp; Vial).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>55</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>45</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Propofol — Voie injectable (Seringues)</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Propofol — Voie injectable (Seringues).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>60</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Ropivacaïne — Voie injectable</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Ropivacaïne — Voie injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>Lévobupivacaïne — Voie injectable</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Lévobupivacaïne — Voie injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <TITLE>
                  <P>Midazolam — Voie injectable</P>
               </TITLE>
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Midazolam — Voie injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <TITLE>
                  <P>Bromure de Rocuronium — Voie injectable</P>
               </TITLE>
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Bromure de Rocuronium — Voie injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>50</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <TITLE>
                  <P>Cisatracurium – Voie injectable</P>
               </TITLE>
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Cisatracurium – Voie injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>45</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>55</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <TITLE>
                  <P>Flumazénil – Voie injectable</P>
               </TITLE>
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="BE3"/>
               <MAIN_SITE>
                  <P>Plusieurs lieux de livraison.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Fourniture de Flumazénil – Voie injectable.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Qualité technique</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>60</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 237-492209</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>1</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Propofol — Voie injectable (Ampoule &amp; Vial)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-15</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Fresenius Kabi SA</OFFICIALNAME>
                     <ADDRESS>Brandekensweg 9</ADDRESS>
                     <TOWN>Schelle</TOWN>
                     <POSTAL_CODE>2627</POSTAL_CODE>
                     <COUNTRY VALUE="BE"/>
                     <n2016:NUTS CODE="BE211"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">760000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>2</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Lévobupivacaïne — Voie injectable</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-15</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Abbvie SA</OFFICIALNAME>
                     <ADDRESS>Avenue Einstein 14</ADDRESS>
                     <TOWN>Wavre</TOWN>
                     <POSTAL_CODE>1300</POSTAL_CODE>
                     <COUNTRY VALUE="BE"/>
                     <E_MAIL>sam.smida@abbvie.com</E_MAIL>
                     <n2016:NUTS CODE="BE310"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">560000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>3</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Midazolam — Voie injectable</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-15</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>B Braun Medical SA</OFFICIALNAME>
                     <ADDRESS>Lambroekstraat 5b</ADDRESS>
                     <TOWN>Diegem</TOWN>
                     <POSTAL_CODE>1831</POSTAL_CODE>
                     <COUNTRY VALUE="BE"/>
                     <n2016:NUTS CODE="BE241"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">160000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>4</CONTRACT_NO>
            <LOT_NO>6</LOT_NO>
            <TITLE>
               <P>Bromure de Rocuronium — Voie injectable</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-15</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Fresenius Kabi SA</OFFICIALNAME>
                     <ADDRESS>Brandekensweg 9</ADDRESS>
                     <TOWN>Schelle</TOWN>
                     <POSTAL_CODE>2627</POSTAL_CODE>
                     <COUNTRY VALUE="BE"/>
                     <n2016:NUTS CODE="BE211"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">400000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="5">
            <CONTRACT_NO>5</CONTRACT_NO>
            <LOT_NO>8</LOT_NO>
            <TITLE>
               <P>Flumazénil – Voie injectable</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-15</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>B Braun Medical S.A.</OFFICIALNAME>
                     <ADDRESS>Lambroekstraat 5b</ADDRESS>
                     <TOWN>Diegem</TOWN>
                     <POSTAL_CODE>1831</POSTAL_CODE>
                     <COUNTRY VALUE="BE"/>
                     <n2016:NUTS CODE="BE241"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">100000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>Lot 2 ((Propofol — Voie injectable (Seringues)): sur base d’avis reçus et argumentés par l’ensemble des représentants du corps médical des institutions, le Pouvoir adjudicateur a décidé de ne pas attribuer ce lot.</P>
               <P>Lot 3 (Ropivacaïne — Voie injectable) et lot 7 (Cisatracurium – Voie injectable): aucune offre n'a été reçue pour ces deux lots.</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Conseil d'État</OFFICIALNAME>
               <TOWN>Bruxelles</TOWN>
               <POSTAL_CODE>5101</POSTAL_CODE>
               <COUNTRY VALUE="BE"/>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_MEDIATION_BODY>
               <OFFICIALNAME>N/A</OFFICIALNAME>
               <TOWN>Belgique</TOWN>
               <COUNTRY VALUE="BE"/>
            </ADDRESS_MEDIATION_BODY>
            <REVIEW_PROCEDURE>
               <P>Voir cahier des charges.</P>
            </REVIEW_PROCEDURE>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>ACAH ASBL</OFFICIALNAME>
               <ADDRESS>Rue de la Pavée 8</ADDRESS>
               <TOWN>Erpent</TOWN>
               <POSTAL_CODE>5101</POSTAL_CODE>
               <COUNTRY VALUE="BE"/>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-02-20</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
